triazoles has been researched along with 4,5-dihydro-1h-1,2,4-triazol-5-one in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kahveci, B; Mendil, D; Soylak, M; Tuzen, M; Uluozlu, OD | 1 |
| Kaczor, AA; Karczmarzyk, Z; Matosiuk, D; Pitucha, M; Rzymowska, J; Wysocki, W | 1 |
2 other study(ies) available for triazoles and 4,5-dihydro-1h-1,2,4-triazol-5-one
| Article | Year |
|---|---|
3-Ethyl-4-(p-chlorobenzylidenamino-4,5-dihydro-1H-1,2,4-triazol-5-one (EPHBAT) as precipitant for carrier element free coprecipitation and speciation of chromium(III) and chromium(VI).
Topics: Chromium; Dose-Response Relationship, Drug; Hydrogen-Ion Concentration; Ions; Plant Leaves; Spectrophotometry, Atomic; Time Factors; Trace Elements; Triazoles; Water Pollutants, Chemical; Water Purification | 2009 |
Structural and molecular docking studies of 4-benzyl-3-[(1-methylpyrrol- 2-yl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one with anticancer activity.
Topics: Antineoplastic Agents; Binding Sites; Cell Line; Cell Line, Tumor; Crystallography, X-Ray; Female; Humans; Isomerism; Molecular Docking Simulation; Molecular Structure; Ovarian Neoplasms; Pyrroles; Triazoles | 2013 |